Fondaparinux versus enoxaparin for the prevention of venous thromboembolism

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.4, 2002-04, pp. : 455-457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The safety of fondaparinux for the prevention and treatment of venous thromboembolism

By Turpie Alexander GG  

Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. : 707-721

Informa Healthcare

Access to resources Recommend Favorite

Enoxaparin: In the Prevention of Venous Thromboembolism in Medical Patients

By Warner G.T.   Perry C.M.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 477-481

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer's Perspective

By Duran Aurea  

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 87-101

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism: Use in Patients Undergoing Major Orthopaedic Surgery

By Sullivan S.D.  

PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. : 605-620

Adis International

Access to resources Recommend Favorite

Fondaparinux Sodium: A Review of its Use in the Prevention of Venous Thromboembolism Following Major Orthopaedic Surgery

By Neil A. Reynolds   Caroline M. Perry   Lesley J. Scott  

Drugs, Vol. 64, Iss. 14, 2004-01 ,pp. : 1575-1596

Adis International

Access to resources Recommend Favorite